| Overview |
| bsm-52014m |
| Alpha-Synuclein (2G5) Monoclonal Antibody |
| WB |
| Human |
| Specifications |
| Unconjugated |
| Mouse |
| Synthetic peptide derived from human Alpha-Synuclein, around 1-30aa. |
| Monoclonal |
| #REF! |
| IgG1 |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C for 12 months. |
| Target |
| 6622 |
| P37840 |
| PD1; NACP; PARK1; PARK4; Alpha-synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; SNCA |
| May be involved in the regulation of dopamine release and transport. Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation. |
| Application Dilution |
| WB |
1:300-5000 |